Literature DB >> 8893714

Clinical significance of diffuse dural enhancement detected by magnetic resonance imaging.

Y River1, A Schwartz, J M Gomori, D Soffer, T Siegal.   

Abstract

This study was performed to determine the clinical significance of diffuse dural enhancement (DDE) detected by magnetic resonance (MR) imaging and to typify enhancing patterns related to inflammatory or metastatic causes. The authors retrospectively evaluated the clinical, imaging, and laboratory characteristics of 20 consecutive patients with DDE. Those with DDE and an underlying neoplastic disease (13 patients) were compared to 11 consecutive patients with cytological evidence of neoplastic leptomeningeal metastasis evaluated by MR imaging. The DDE was often associated with an underlying malignancy (13 (65%) of 20 patients) but it coexisted with leptomeningeal metastasis in only one patient. Skull metastases were evident in 10 (77%) of 13 patients and cranial nerve palsies in six (46%) of 13. Other causes of DDE were related to cerebrospinal fluid (CSF) leak or shunting (five (25%) of 20), with or without symptoms of intracranial hypotension, and to dural sinus thrombosis and pachymeningitis. Dural biopsies obtained in two patients with DDE showed a narrow rim of granulation-like tissue adherent to the dural surface facing the inner skull table. Magnetic resonance subtraction, diffusion, and perfusion studies revealed unique characteristics in patients with metastatic causes as compared to those with DDE secondary to CSF leak. None of the patients with proven leptomeningeal metastasis had DDE, but four of them presented with focal dural enhancement and two displayed apparent leptomeningeal enhancement. The findings indicate that DDE is not a radiographic hallmark of leptomeningeal metastasis in spite of the similarities in clinical manifestations (for example, headache and cranial polyneuropathy). Nonetheless, DDE is most frequently associated with metastatic malignancies and particularly with skull metastases and CSF leak. Special MR techniques can discern the underlying cause and elucidate the disparity in the pathophysiological mechanisms leading to DDE.

Entities:  

Mesh:

Year:  1996        PMID: 8893714     DOI: 10.3171/jns.1996.85.5.0777

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  7 in total

1.  Primary diffuse meningeal melanomatosis: radiologic-pathologic correlation.

Authors:  Maria-Giulia Pirini; Mario Mascalchi; Fabrizio Salvi; Carlo A Tassinari; Licciana Zanella; Patrizia Bacchini; Franco Bertoni; Antonia D'Errico; Barbara Corti; Walter F Grigioni
Journal:  AJNR Am J Neuroradiol       Date:  2003-01       Impact factor: 3.825

Review 2.  Dural metastases.

Authors:  Florence Laigle-Donadey; Sophie Taillibert; Karima Mokhtari; Jerzy Hildebrand; Jean-Yves Delattre
Journal:  J Neurooncol       Date:  2005-10       Impact factor: 4.130

3.  Wave-like appearance of diffuse pachymeningeal enhancement associated with intracranial hypotension.

Authors:  M Tosaka; N Sato; H Fujimaki; A Takahashi; N Saito
Journal:  Neuroradiology       Date:  2005-05-11       Impact factor: 2.804

4.  Dural enhancement and thickening in acute mastoiditis.

Authors:  Shay Shemesh; Tal Marom; Dominique Ben Ami Raichman; Sharon Ovnat Tamir
Journal:  Neuroradiol J       Date:  2015-05-11

5.  Comparison of endoscopic and external resections for sinonasal instestinal-type adenocarcinoma.

Authors:  Geoffrey Mortuaire; Xavier Leroy; Claire Vandenhende-Szymanski; Dominique Chevalier; Anne-Sophie Thisse
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-06-30       Impact factor: 2.503

6.  Diagnosis and temporal evolution of signs of intracranial hypotension on MRI of the brain.

Authors:  R Forghani; R I Farb
Journal:  Neuroradiology       Date:  2008-09-16       Impact factor: 2.804

7.  Cerebral Venous Sinus Thrombosis Presenting with Features of Raised Intracranial Tension and En Plaque Meningeal Thickening; A Case Report.

Authors:  Arpit Agrawal; Chintan Prajapati; V Y Vishnu; M V Padma Srivastava; Vinay Goyal; M B Singh; Ajay Garg; Manmohan Singh
Journal:  Ann Indian Acad Neurol       Date:  2022-02-22       Impact factor: 1.383

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.